Mark Talamonti to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Mark Talamonti has written about Dose-Response Relationship, Drug.
Connection Strength
0.071
-
Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol. 2000 Oct 01; 18(19):3384-9.
Score: 0.034
-
Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer. 2006 Dec 29; 5:76.
Score: 0.013
-
A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. Biochem Biophys Res Commun. 2006 Feb 24; 340(4):1224-8.
Score: 0.012
-
Identification and in silico characterization of a novel gene: TPA induced trans-membrane protein. Biochem Biophys Res Commun. 2005 Apr 08; 329(2):755-64.
Score: 0.012